6505--Contingency Medication Compounding Services

Key Dates
Due Date

-

Posted Date

-

Agency & Value
Agency

256-NETWORK CONTRACT OFFICE 16 (36C256)

Contract Value

Not provided

Codes & Classification
Solicitation Number

36C25626Q0332

NAICS

325412 - Pharmaceutical Preparation Manufacturing

Classification Code

6505

Additional Details
Set Aside

None

Place of Performance

Houston, TX

SourceSAM
Documents3
The Department of Veterans Affairs, through its 256-Network Contract Office 16, has issued a combined synopsis/solicitation for Contingency Medication Compounding Services under procurement identifier 36C25626Q0332. This procurement seeks qualified vendors to provide pharmaceutical compounding services in support of contingency operations at the VA facility located in Houston, Texas. The scope of this requirement encompasses the preparation and supply of compounded medications, ensuring continuity of care for veterans during periods of increased demand or supply chain disruptions. The intended outcome is to secure reliable access to compounded pharmaceuticals, tailored to the specific needs of the VA medical center, thereby supporting patient safety and operational readiness. Key requirements include the ability to supply compounded medications from both 503A and 503B facilities. The government has clarified that medications sourced from 503B outsourcing facilities will be accepted, provided the pharmacy is licensed by the state or registered with the FDA. This flexibility allows for a broader range of qualified suppliers, ensuring compliance with regulatory standards and maintaining high quality in pharmaceutical preparations. The procurement is classified under NAICS code 325412 (Pharmaceutical Preparation Manufacturing), with the relevant product service code being 6505. The place of performance is specified as Houston, TX, indicating that services and deliveries will be directed to this location. The contracting entity is the 256-Network Contract Office 16, a federal office within the Department of Veterans Affairs. The primary point of contact for this solicitation is Eugene Jackson, who can be reached at [email protected] or by phone at 713-350-2938 for further inquiries. This solicitation is currently active, with the deadline for RFQ submissions extended to 3:00pm on February 18, 2026, following an amendment that also addressed vendor questions. Interested contractors should review the three attachments available on the SAM.gov opportunity page for detailed requirements and submission instructions. There are no explicit set-aside requirements or special considerations noted in the provided information. Contractors should ensure their facilities meet the licensing and registration criteria outlined for 503A and 503B compounding pharmacies and be prepared to deliver high-quality compounded medications in accordance with VA standards. This opportunity represents a critical support function for the VA, focusing on the consistent and compliant provision of compounded pharmaceuticals to meet contingency needs. Contractors with proven capabilities in pharmaceutical preparation and compounding, particularly those operating FDA-registered or state-licensed facilities, are encouraged to evaluate this solicitation for alignment with their service offerings.